43 related articles for article (PubMed ID: 9637504)
21. Bound peptide-dependent thermal stability of major histocompatibility complex class II molecule I-Ek.
Saito K; Oda M; Sarai A; Azuma T; Kozono H
Biochemistry; 2004 Aug; 43(31):10186-91. PubMed ID: 15287746
[TBL] [Abstract][Full Text] [Related]
22. Expression of invariant chain can cause an allele-dependent increase in the surface expression of MHC class I molecules.
Reber AJ; Turnquist HR; Thomas HJ; Lutz CT; Solheim JC
Immunogenetics; 2002 May; 54(2):74-81. PubMed ID: 12037599
[TBL] [Abstract][Full Text] [Related]
23. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
24. Class II-associated invariant chain peptide-independent binding of invariant chain to class II MHC molecules.
Thayer WP; Ignatowicz L; Weber DA; Jensen PE
J Immunol; 1999 Feb; 162(3):1502-9. PubMed ID: 9973407
[TBL] [Abstract][Full Text] [Related]
25. Structure of Ia antigens: identification of dimeric complexes formed by the invariant chain.
Koch N; Hämmerling GJ
J Immunol; 1982 Mar; 128(3):1155-8. PubMed ID: 6948896
[TBL] [Abstract][Full Text] [Related]
26. Expression of recombinant HLA-DR2 molecules. Replacement of the hydrophobic transmembrane region by a leucine zipper dimerization motif allows the assembly and secretion of soluble DR alpha beta heterodimers.
Kalandadze A; Galleno M; Foncerrada L; Strominger JL; Wucherpfennig KW
J Biol Chem; 1996 Aug; 271(33):20156-62. PubMed ID: 8702739
[TBL] [Abstract][Full Text] [Related]
27. Increased yields and biological potency of knob-into-hole-based soluble MHC class II molecules.
Serra P; Garabatos N; Singha S; Fandos C; Garnica J; Solé P; Parras D; Yamanouchi J; Blanco J; Tort M; Ortega M; Yang Y; Ellestad KK; Santamaria P
Nat Commun; 2019 Oct; 10(1):4917. PubMed ID: 31664029
[TBL] [Abstract][Full Text] [Related]
28. Rationally designed mutations convert complexes of human recombinant T cell receptor ligands into monomers that retain biological activity.
Huan JY; Meza-Romero R; Mooney JL; Chou YK; Edwards DM; Rich C; Link JM; Vandenbark AA; Bourdette DN; Bächinger HP; Burrows GG
J Chem Technol Biotechnol; 2005 Jan; 80(1):2-12. PubMed ID: 22973070
[TBL] [Abstract][Full Text] [Related]
29. Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactions.
Cohen CJ; Denkberg G; Lev A; Epel M; Reiter Y
J Mol Recognit; 2003; 16(5):324-32. PubMed ID: 14523945
[TBL] [Abstract][Full Text] [Related]
30. Expression and characterization of recombinant soluble peptide: I-A complexes associated with murine experimental autoimmune diseases.
Radu CG; Ober BT; Colantonio L; Qadri A; Ward ES
J Immunol; 1998 Jun; 160(12):5915-21. PubMed ID: 9637504
[TBL] [Abstract][Full Text] [Related]
31. Single-chain MHC class II molecules induce T cell activation and apoptosis.
Rhode PR; Burkhardt M; Jiao J; Siddiqui AH; Huang GP; Wong HC
J Immunol; 1996 Dec; 157(11):4885-91. PubMed ID: 8943392
[TBL] [Abstract][Full Text] [Related]
32. Two-domain MHC class II molecules form stable complexes with myelin basic protein 69-89 peptide that detect and inhibit rat encephalitogenic T cells and treat experimental autoimmune encephalomyelitis.
Burrows GG; Bebo BF; Adlard KL; Vandenbark AA; Offner H
J Immunol; 1998 Dec; 161(11):5987-96. PubMed ID: 9834080
[TBL] [Abstract][Full Text] [Related]
33. The inability of the nonobese diabetic class II molecule to form stable peptide complexes does not reflect a failure to interact productively with DM.
Peterson M; Sant AJ
J Immunol; 1998 Sep; 161(6):2961-7. PubMed ID: 9743359
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of chicken major histocompatibility complex class II oligomers using a baculovirus expression system.
Niemiec PK; Read LR; Sharif S
Protein Expr Purif; 2006 Apr; 46(2):390-400. PubMed ID: 16236525
[TBL] [Abstract][Full Text] [Related]
35. The assembly and stability of MHC class II-(alpha beta)2 superdimers.
Schafer PH; Malapati S; Hanfelt KK; Pierce SK
J Immunol; 1998 Sep; 161(5):2307-16. PubMed ID: 9725225
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
